44. Ojetti V., Bruno G., Ainora M.E., Gigante G., Rizzo G., Roccarina D., et al. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. Gastroenterol Res Pract. 2012;2012:740381. DOI: 10.1155/2012/740381
45. Ли И.А., Сильвестрова С.Ю., Дроздов В.Н. Пробиотик Риофлора Баланс Нео и антихеликобактерная терапия — повышение эффективности лечения за счет снижения нежелательных явлений. Медицинский Совет. 2013;10:100–3. [ Li I.A., Silvestrova S.Yu., Drozdov V.N. “Rioflora Balans Neo” probiotic and anti-Helicobacter therapy: increased efficacy at reduced adverse events. Medical Council. 2013;(10):100–3 (In Russ.)]. DOI: 10.21518/2079-701X-2013-10-100-103
46. Ducrotté P., Sawant P., Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol. 2012;18(30):4012–8. DOI: 10.3748/wjg.v18.i30.4012
47. Ford A.C., Quigley E.M., Lacy B.E., Lembo A.J., Saito Y.A., Schiller L.R., et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(10):1547–61; quiz 1546, 1562. DOI: 10.1038/ajg.2014.202
48. Choi C.H., Jo S.Y., Park H.J., Chang S.K., Byeon J.S., Myung S.J. A randomized, double-blind, placebocontrolled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol. 2011;45(8):679–83. DOI: 10.1097/ MCG.0b013e318204593e
49. Whorwell P.J., Altringer L., Morel J., Bond Y., Charbonneau D., O’Mahony L., et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581–90. DOI: 10.1111/j.1572- 0241.2006.00734.x
50. Moayyedi P., Ford A.C., Talley N.J., Cremonini F., Foxx-Orenstein A.E., Brandt L.J., et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325–32. DOI: 10.1136/gut.2008.167270
51. Lorenzo-Zúñiga V., Llop E., Suárez C., Álvarez B., Abreu L., Espadaler J., et al. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol. 2014;20(26):8709– 16. DOI: 10.3748/wjg.v20.i26.8709
52. Ivashkin V., Drapkina O., Poluektova Ye., Kuchumova S., Sheptulin A., Shifrin O. The Effect of a Multistrain Probiotic on the Symptoms and Small Intestinal Bacterial Overgrowth in Constipation-predominant Irritable Bowel Syndrome: A Randomized, Simple-blind, Placebo-controlled Trial. American Journal of Clinical Medicine Research. 2015;3(2):18–23. DOI: 10.12691/ajcmr-3-2-1
53. Guyonnet D., Schlumberger A., Mhamdi L., Jakob S., Chassany O. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomized, double-blind, parallel, controlled study. British Journal of Nutrition, 2009;102(11):1654– 62. DOI: 10.1111/j.1365-2036.2007.03362.x
54. Jafari E., Vahedi H., Merat S., Momtahen S., Riahi A. Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating. Arch Iran Med. 2014;17(7):466–70. DOI: 0141707/AIM.003
55. Yang Y.X., He M., Hu G., Wei J., Pages P., Yang X.H., et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol. 2008;14(40):6237–43. DOI: 10.3748/wjg.14.6237
56. Ojetti V., Ianiro G., Tortora A., D’Angelo G., Di Rienzo T.A., Bibbò S., et al. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. J Gastrointest Liver Dis JGLD. 2014;23(4):387–91. DOI: 10.15403/jgld.2014.1121.234.elr
57. Schumann C. Medical, nutritional and technological properties of lactulose. An update. Eur J Nutr. 2002;41 Suppl 1:I17–25. DOI: 10.1007/s00394-002-1103-6
58. Nyman M. Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose.
Br J Nutr. 2002;87 Suppl 2:S163–8. DOI: 10.1079/BJNBJN/2002533
59. Eales J., Gibson P.R., Whorwell P.J., Kellow J., Yellowlees A., Perry R., et al. Systematic review and metaanalysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol. 2017;10(1):74–88. DOI: 10.1177/1756283X16670075
60. Gluud L.L., Vilstrup H., Morgan M.Y. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;4:CD003044. DOI: 10.1002/14651858. CD003044.pub3
61. Szajewska H., Guarino A., Hojsak I., Indrio F., Kolacek S., Shamir R., et al.; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr.
2014;58(4):531–9. DOI: 10.1097/MPG.0000000000000320
62. Szajewska H., Skórka A., Ruszczyński M., GieruszczakBiałek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children--updated analysis of randomised controlled trials. Aliment Pharmacol Ther. 2013;38(5):467–76. DOI: 10.1111/apt.12403
63. Szajewska H., Skórka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated metaanalysis of randomized controlled trials. Aliment Pharmacol Ther. 2009;30(9):960–1. DOI: 10.1111/j.13652036.2009.04113.x
64. Szajewska H., Kołodziej M. Systematic review with metaanalysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149–57. DOI: 10.1111/apt.13404